BDO Wealth Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $114K | Buy |
1,314
+43
| +3% | +$3.73K | 0.01% | 325 |
|
|
2023
Q1 | $124K | Hold |
1,271
| – | – | 0.02% | 301 |
|
|
2022
Q4 | $132K | Hold |
1,271
| – | – | 0.02% | 302 |
|
|
2022
Q3 | $108K | Hold |
1,271
| – | – | 0.01% | 318 |
|
|
2022
Q2 | $105K | Buy |
1,271
+60
| +5% | +$4.96K | 0.01% | 318 |
|
|
2022
Q1 | $93K | Sell |
1,211
-18
| -1% | -$1.38K | 0.01% | 346 |
|
|
2021
Q4 | $109K | Buy |
1,229
+18
| +1% | +$1.6K | 0.01% | 344 |
|
|
2021
Q3 | $94K | Hold |
1,211
| – | – | 0.01% | 360 |
|
|
2021
Q2 | $101K | Buy |
1,211
+11
| +0.9% | +$917 | 0.01% | 369 |
|
|
2021
Q1 | $91K | Hold |
1,200
| – | – | 0.01% | 368 |
|
|
2020
Q4 | $105K | Hold |
1,200
| – | – | 0.01% | 282 |
|
|
2020
Q3 | $91K | Sell |
1,200
-25
| -2% | -$1.9K | 0.01% | 277 |
|
|
2020
Q2 | $151K | Hold |
1,225
| – | – | 0.03% | 245 |
|
|
2020
Q1 | $104K | Buy |
1,225
+25
| +2% | +$2.12K | 0.02% | 267 |
|
|
2019
Q4 | $101K | Hold |
1,200
| – | – | 0.03% | 248 |
|
|
2019
Q3 | $81K | Hold |
1,200
| – | – | 0.02% | 269 |
|
|
2019
Q2 | $103K | Hold |
1,200
| – | – | 0.03% | 241 |
|
|
2019
Q1 | $107K | Sell |
1,200
-450
| -27% | -$40.1K | 0.03% | 217 |
|
|
2018
Q4 | $140K | Buy |
1,650
+300
| +22% | +$25.5K | 0.05% | 183 |
|
|
2018
Q3 | $131K | Hold |
1,350
| – | – | 0.04% | 189 |
|
|
2018
Q2 | $127K | Buy |
+1,350
| New | +$127K | 0.04% | 195 |
|